AEterna Zentaris subsidiary, Atrium Biotechnologies, acquires Douglas Laboratories in the U.S.

AEterna Zentaris subsidiary, Atrium Biotechnologies, acquires Douglas Laboratories in the U.S. Atrium Biotechnologies Inc. has acquired HVL Inc., whose main brand is Douglas Laboratories for the total amount of $107 million ($US 92 million), approximately 6.4 times the adjusted EBITDA generated by Douglas.
Home Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava Modern Science Confirms Ancient Wisdom! Modern Science Confirms Ancient Wisdom! "Natural" or "Plant-Derived" Labeling Can Mislead CDN: Natural Health Products Report - Update NPI Editorial: Are we using Best Practices? AHPA Update: Kava Information from the AHPA Executive Committee European Commission Proposes Registration Scheme for Herbal Medicine to Avoid Need for Testing Statement on Kava in New Zealand BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning New XanoMax® Trademark for Renaissance Herbs The USPTO has awarded trademark registration No. 2,995,810 for Renaissance’s XanoMax® brand of standardized Mangosteen extracts. New XanoMax® Trademark for Renaissance Herbs The USPTO has awarded trademark registration No. 2,995,810 for Renaissance’s XanoMax® brand of standardized Mangosteen extracts. New XanoMax® Trademark for Renaissance Herbs The USPTO has awarded trademark registration No. 2,995,810 for Renaissance’s XanoMax® brand of standardized Mangosteen extracts. Oasis LifeSciences Files Intellectual Property Lawsuit Company has filed suit in United States District Court for the District of Colorado against Resource Maxima LLC, Gary Coe, and Sandra Coe for trademark infringement, unfair competition, misappropriation of business value, and patent infringement, and against SOE Trading and Management for patent infringement. Oasis LifeSciences Files Intellectual Property Lawsuit Company has filed suit in United States District Court for the District of Colorado against Resource Maxima LLC, Gary Coe, and Sandra Coe for trademark infringement, unfair competition, misappropriation of business value, and patent infringement, and against SOE Trading and Management for patent infringement. Biogaia Signs Agreement In Austria Company has signed a 5-year agreement with HSO Pharma giving the company exclusive rights to market the BioGaia dental products, tablets and baby drops in pharmacies and clinics in Austria. Biogaia Signs Agreement In Austria Company has signed a 5-year agreement with HSO Pharma giving the company exclusive rights to market the BioGaia dental products, tablets and baby drops in pharmacies and clinics in Austria. Biogaia Signs Agreement In Austria Company has signed a 5-year agreement with HSO Pharma giving the company exclusive rights to market the BioGaia dental products, tablets and baby drops in pharmacies and clinics in Austria. Biogaia Signs Agreement In Austria Company has signed a 5-year agreement with HSO Pharma giving the company exclusive rights to market the BioGaia dental products, tablets and baby drops in pharmacies and clinics in Austria. Biogaia Signs Agreement In Austria Company has signed a 5-year agreement with HSO Pharma giving the company exclusive rights to market the BioGaia dental products, tablets and baby drops in pharmacies and clinics in Austria. Nutraceutical Reports Sales and Income Company reports net sales for the fiscal 2005 fourth quarter were $36.8 million compared to $36.1 million for the same quarter prior year, with net income of $3.0 million, or $0.26 diluted earnings per share, compared to $3.3 million, or $0.28 diluted earnings per share prior year. Nutraceutical Reports Sales and Income Company reports net sales for the fiscal 2005 fourth quarter were $36.8 million compared to $36.1 million for the same quarter prior year, with net income of $3.0 million, or $0.26 diluted earnings per share, compared to $3.3 million, or $0.28 diluted earnings per share prior year. Resource Maxima Responds to Allegations Company challenges the allegations made by Oasis. Resource Maxima Responds to Allegations Company challenges the allegations made by Oasis. Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work. Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work. Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work. Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work. Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work. Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work. Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work. Tate & Lyle Announces Acquisition of Food Ingredient Companies Company announces the signing of agreements to acquire US specialty food ingredients company Continental Custom Ingredients and the Italian based Cesalpinia group of companies. Tate & Lyle Announces Acquisition of Food Ingredient Companies Company announces the signing of agreements to acquire US specialty food ingredients company Continental Custom Ingredients and the Italian based Cesalpinia group of companies. Former Production Manager for Kraft, Frito-Lay and Elan Nutrition Joins Sweet Success Thomas Colbourn has joined the Company as the new director of product supply. Former Production Manager for Kraft, Frito-Lay and Elan Nutrition Joins Sweet Success Thomas Colbourn has joined the Company as the new director of product supply. Former Production Manager for Kraft, Frito-Lay and Elan Nutrition Joins Sweet Success Thomas Colbourn has joined the Company as the new director of product supply. Former Production Manager for Kraft, Frito-Lay and Elan Nutrition Joins Sweet Success Thomas Colbourn has joined the Company as the new director of product supply. Natural Alternatives International, Inc. Announces Acquisition of Real Health Laboratories, Inc. Company announces the acquisition of Real Health Laboratories, Inc.(RHL); RHL had approximately $11.6 million in revenue in its latest fiscal year, selling supplements through US retailers. Natural Alternatives International, Inc. Announces Acquisition of Real Health Laboratories, Inc. Company announces the acquisition of Real Health Laboratories, Inc.(RHL); RHL had approximately $11.6 million in revenue in its latest fiscal year, selling supplements through US retailers. Planet Organic Health Corp Named to 2005 TSX Venture 50 Company named to the 2005 TSX Venture 50(TM), the first ever ranking of Canada's top emerging public companies listed on TSX Venture Exchange. Planet Organic Health Corp Named to 2005 TSX Venture 50 Company named to the 2005 TSX Venture 50(TM), the first ever ranking of Canada's top emerging public companies listed on TSX Venture Exchange. CV Technologies-Maker of Cold-FX(R)-Named in the '2005 TSX Venture 50' Company has been named the top ranked company in the 2005 TSX Venture 50(TM), the first ever ranking of Canada's top emerging public companies listed on the TSX Venture Exchange. CV Technologies-Maker of Cold-FX(R)-Named in the '2005 TSX Venture 50' Company has been named the top ranked company in the 2005 TSX Venture 50(TM), the first ever ranking of Canada's top emerging public companies listed on the TSX Venture Exchange. Burcon selected for inclusion in TSX Venture 50 Company announces that it has been selected for inclusion in the "2005 TSX Venture 50" a ranking of the top 50 emerging public companies listed on the TSX Venture Exchange. Burcon selected for inclusion in TSX Venture 50 Company announces that it has been selected for inclusion in the "2005 TSX Venture 50" a ranking of the top 50 emerging public companies listed on the TSX Venture Exchange. LycoRed Announces Reorganization reorganization is an integration of all subsidiary companies, Nutriblend, Biodar, Nutriblend International Sàrl, and the latest acquisition, Buckton Scott Nutrition, into one unit, with each region served by a local headquarters. Leo Cullen has been appointed President of LycoRed Corp., David Roberton has been named President of LycoRed Limited, the European headquarters, based in the UK, LycoRed Sàrl in Switzerland serves as the European lycopene technical support center, headed by Joost Overeem. LycoRed Announces Reorganization reorganization is an integration of all subsidiary companies, Nutriblend, Biodar, Nutriblend International Sàrl, and the latest acquisition, Buckton Scott Nutrition, into one unit, with each region served by a local headquarters. Leo Cullen has been appointed President of LycoRed Corp., David Roberton has been named President of LycoRed Limited, the European headquarters, based in the UK, LycoRed Sàrl in Switzerland serves as the European lycopene technical support center, headed by Joost Overeem. LycoRed Announces Reorganization reorganization is an integration of all subsidiary companies, Nutriblend, Biodar, Nutriblend International Sàrl, and the latest acquisition, Buckton Scott Nutrition, into one unit, with each region served by a local headquarters. Leo Cullen has been appointed President of LycoRed Corp., David Roberton has been named President of LycoRed Limited, the European headquarters, based in the UK, LycoRed Sàrl in Switzerland serves as the European lycopene technical support center, headed by Joost Overeem. LycoRed Announces Reorganization reorganization is an integration of all subsidiary companies, Nutriblend, Biodar, Nutriblend International Sàrl, and the latest acquisition, Buckton Scott Nutrition, into one unit, with each region served by a local headquarters. Leo Cullen has been appointed President of LycoRed Corp., David Roberton has been named President of LycoRed Limited, the European headquarters, based in the UK, LycoRed Sàrl in Switzerland serves as the European lycopene technical support center, headed by Joost Overeem. United Natural Foods, Inc. Names Thomas B. Simone Chair of the Board of Directors and Announces Senior Management Promotions Thomas B. Simone was elected Chair of the Board of Directors, Richard Antonelli has been promoted from President of United Distribution to Executive Vice President, Chief Operating Officer and President of Distribution, Daniel V. Atwood has been promoted from Senior Vice President of Marketing to Executive Vice President, Chief Marketing Officer and President of United Natural Brands, Rick D. Puckett, Vice President, Chief Financial Officer and Treasurer, has been promoted from Vice President to Executive Vice President. United Natural Foods, Inc. Names Thomas B. Simone Chair of the Board of Directors and Announces Senior Management Promotions Thomas B. Simone was elected Chair of the Board of Directors, Richard Antonelli has been promoted from President of United Distribution to Executive Vice President, Chief Operating Officer and President of Distribution, Daniel V. Atwood has been promoted from Senior Vice President of Marketing to Executive Vice President, Chief Marketing Officer and President of United Natural Brands, Rick D. Puckett, Vice President, Chief Financial Officer and Treasurer, has been promoted from Vice President to Executive Vice President. United Natural Foods, Inc. Names Thomas B. Simone Chair of the Board of Directors and Announces Senior Management Promotions Thomas B. Simone was elected Chair of the Board of Directors, Richard Antonelli has been promoted from President of United Distribution to Executive Vice President, Chief Operating Officer and President of Distribution, Daniel V. Atwood has been promoted from Senior Vice President of Marketing to Executive Vice President, Chief Marketing Officer and President of United Natural Brands, Rick D. Puckett, Vice President, Chief Financial Officer and Treasurer, has been promoted from Vice President to Executive Vice President. United Natural Foods, Inc. Names Thomas B. Simone Chair of the Board of Directors and Announces Senior Management Promotions Thomas B. Simone was elected Chair of the Board of Directors, Richard Antonelli has been promoted from President of United Distribution to Executive Vice President, Chief Operating Officer and President of Distribution, Daniel V. Atwood has been promoted from Senior Vice President of Marketing to Executive Vice President, Chief Marketing Officer and President of United Natural Brands, Rick D. Puckett, Vice President, Chief Financial Officer and Treasurer, has been promoted from Vice President to Executive Vice President. Zila Announces Its Fiscal 2006 First Quarter Financial Results Company reports net revenues of $9.7, compared to net revenues of $9.9 million prior year, as Zila Nutraceuticals revenue decreased $1.3 million with gross margin decreasing 58% in the first quarter of fiscal 2006 from 65% in the prior year period, driven primarily by discounts offered in an effort to stimulate Ester-C(R) sales. Zila Announces Its Fiscal 2006 First Quarter Financial Results Company reports net revenues of $9.7, compared to net revenues of $9.9 million prior year, as Zila Nutraceuticals revenue decreased $1.3 million with gross margin decreasing 58% in the first quarter of fiscal 2006 from 65% in the prior year period, driven primarily by discounts offered in an effort to stimulate Ester-C(R) sales. Global Nutraceuticals Group named Exclusive US Distributor of PhytoShield(TM) Toothpastes The New Zealand Natural Oral Care Company announced it has named Global Nutraceuticals Group of San Francisco, California Exclusive US Wholesale Distributor for its PhytoShield(TM) science-based, non-flouridated toothpastes. Global Nutraceuticals Group named Exclusive US Distributor of PhytoShield(TM) Toothpastes The New Zealand Natural Oral Care Company announced it has named Global Nutraceuticals Group of San Francisco, California Exclusive US Wholesale Distributor for its PhytoShield(TM) science-based, non-flouridated toothpastes. Global Nutraceuticals Group named Exclusive US Distributor of PhytoShield(TM) Toothpastes The New Zealand Natural Oral Care Company announced it has named Global Nutraceuticals Group of San Francisco, California Exclusive US Wholesale Distributor for its PhytoShield(TM) science-based, non-flouridated toothpastes. Global Nutraceuticals Group named Exclusive US Distributor of PhytoShield(TM) Toothpastes The New Zealand Natural Oral Care Company announced it has named Global Nutraceuticals Group of San Francisco, California Exclusive US Wholesale Distributor for its PhytoShield(TM) science-based, non-flouridated toothpastes. American Oriental Bioengineering, Inc. Closes $60 Million Private Placement Company has closed its private offering to accredited investors of 12.5 million units at a price of $4.80 per unit, for gross proceeds of $60 million which will be used for potential acquisitions and general corporate purposes. American Oriental Bioengineering, Inc. Closes $60 Million Private Placement Company has closed its private offering to accredited investors of 12.5 million units at a price of $4.80 per unit, for gross proceeds of $60 million which will be used for potential acquisitions and general corporate purposes. Neptune Technologies & Bioressources Inc. Announces Strategic Alliances with Degussa AG The alliance between Neptune and Degussa AG includes a two-tier project with a common objective to expand the Neptune pipeline. With Degussa’s AG expertise in supercritical CO2 extraction, Neptune will complete the enhancement of Neptune Krill Oil properties, customized for different functional foods and also complete the extraction process, isolation and industrial production of Neptune’s novel phospholipids. Neptune Technologies & Bioressources Inc. Announces Strategic Alliances with Degussa AG The alliance between Neptune and Degussa AG includes a two-tier project with a common objective to expand the Neptune pipeline. With Degussa’s AG expertise in supercritical CO2 extraction, Neptune will complete the enhancement of Neptune Krill Oil properties, customized for different functional foods and also complete the extraction process, isolation and industrial production of Neptune’s novel phospholipids. Neptune Technologies & Bioressources Inc. Announces Strategic Alliances with Degussa AG The alliance between Neptune and Degussa AG includes a two-tier project with a common objective to expand the Neptune pipeline. With Degussa’s AG expertise in supercritical CO2 extraction, Neptune will complete the enhancement of Neptune Krill Oil properties, customized for different functional foods and also complete the extraction process, isolation and industrial production of Neptune’s novel phospholipids. Neptune Technologies & Bioressources Inc. Announces Strategic Alliances with Degussa AG The alliance between Neptune and Degussa AG includes a two-tier project with a common objective to expand the Neptune pipeline. With Degussa’s AG expertise in supercritical CO2 extraction, Neptune will complete the enhancement of Neptune Krill Oil properties, customized for different functional foods and also complete the extraction process, isolation and industrial production of Neptune’s novel phospholipids. Zila Signs Agreements to Expand Market Coverage for Ester-C(R) Products in the Scandinavian Region Company has signed two separate agreements with Cederroth International and Bringwell AB to expand its market presence in the Scandinavian region. Zila Signs Agreements to Expand Market Coverage for Ester-C(R) Products in the Scandinavian Region Company has signed two separate agreements with Cederroth International and Bringwell AB to expand its market presence in the Scandinavian region. Zila Signs Agreements to Expand Market Coverage for Ester-C(R) Products in the Scandinavian Region Company has signed two separate agreements with Cederroth International and Bringwell AB to expand its market presence in the Scandinavian region. Zila Signs Agreements to Expand Market Coverage for Ester-C(R) Products in the Scandinavian Region Company has signed two separate agreements with Cederroth International and Bringwell AB to expand its market presence in the Scandinavian region. Zila Signs Agreements to Expand Market Coverage for Ester-C(R) Products in the Scandinavian Region Company has signed two separate agreements with Cederroth International and Bringwell AB to expand its market presence in the Scandinavian region. SunOpta, Inc. Appoints Steven Townsend to Board of Directors Company announces the appointment of Steven Townsend, formerly President, Chief Executive Officer and Chairman of United Natural Foods, Inc., to the Company's Board of Directors. SunOpta, Inc. Appoints Steven Townsend to Board of Directors Company announces the appointment of Steven Townsend, formerly President, Chief Executive Officer and Chairman of United Natural Foods, Inc., to the Company's Board of Directors. SunOpta, Inc. Appoints Steven Townsend to Board of Directors Company announces the appointment of Steven Townsend, formerly President, Chief Executive Officer and Chairman of United Natural Foods, Inc., to the Company's Board of Directors. SunOpta, Inc. Appoints Steven Townsend to Board of Directors Company announces the appointment of Steven Townsend, formerly President, Chief Executive Officer and Chairman of United Natural Foods, Inc., to the Company's Board of Directors. Immune System Management Inc. purchases intellectual property to market nutraceutical compounds Company has purchased intellectual property pertaining to Aminomics developed by William O'Neill, the founder and CEO of the Canadian Cancer Research Group. Immune System Management Inc. purchases intellectual property to market nutraceutical compounds Company has purchased intellectual property pertaining to Aminomics developed by William O'Neill, the founder and CEO of the Canadian Cancer Research Group. Jarrow Formulas® Signs Agreement With CareNet China Company has signed an agreement to be a major supplier of nutritional supplements to CareNet China, a Chinese health care company. Jarrow Formulas® Signs Agreement With CareNet China Company has signed an agreement to be a major supplier of nutritional supplements to CareNet China, a Chinese health care company. Martek Announces Fourth Quarter and FY 2005 Financial Results Company reports revenues of $56.0 million compared to $59.7 million for the fourth quarter of fiscal 2004 , with income before income taxes of $7.7 million compared to income before income taxes of $10.1 million for the same quarter prior year. Martek Announces Fourth Quarter and FY 2005 Financial Results Company reports revenues of $56.0 million compared to $59.7 million for the fourth quarter of fiscal 2004 , with income before income taxes of $7.7 million compared to income before income taxes of $10.1 million for the same quarter prior year. Tate & Lyle Interim Results Announcement 2009 Tate & Lyle has announced their 2009 Interim results, reporting the Group's performance, before the impact of exchange translation, remains on track to meet our expectations for the full year. NPI Daily - Top of The News for Nov. 6, 2009 - National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters Nature's Sunshine Products Reports FY09 Q3 Operating Results; SunOpta Announces FY09 Q3 Results; Tate & Lyle Interim Results Announcement 2009; NOW Foods Receives the 2009 Illinois Governor's Sustainability Award; Transport-C Supports Vitamin Angels at SSW; Cantox at Supplyside West; New Support Showing Immunoglobulin Supplementation Enhances Immune System; FDA Warning: Over-the-Counter Sex Enhancement Drug May Cause 'Dangerously' Low Blood Pressure; EPAX AS Achieves 'Friend of the Sea' Certification; National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters; Fast-C™ At SupplySide West: US Clinical Trials Data Available In Booth ; Nutty Flavor & Healthy Boost of Omega-3 Make Hemp Seed an Ideal Ingredient; DSM's tensVida® Recognized for Innovative Development; Nutrition 21 Announces Addition of Innovative New Probiotic + Omega-3 Fish Oil Combination Product; Glanbia Nutritionals Offers More Than Ingredients for Nutritional Beverages; Whole Foods Market(R) Offers Natural Solutions to Help Build Up Body Defenses With Immune System Support; Doug Reyes Joins Embria as Regional Sales Manager; Michael F. Hines Joins Board of General Nutrition Centers, Inc.; Dr. Arnold Hirsch Celebrates 50th Anniversary with the American Chemical Society NPI Daily - Top of The News for Nov. 6, 2009 - National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters Nature's Sunshine Products Reports FY09 Q3 Operating Results; SunOpta Announces FY09 Q3 Results; Tate & Lyle Interim Results Announcement 2009; NOW Foods Receives the 2009 Illinois Governor's Sustainability Award; Transport-C Supports Vitamin Angels at SSW; Cantox at Supplyside West; New Support Showing Immunoglobulin Supplementation Enhances Immune System; FDA Warning: Over-the-Counter Sex Enhancement Drug May Cause 'Dangerously' Low Blood Pressure; EPAX AS Achieves 'Friend of the Sea' Certification; National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters; Fast-C™ At SupplySide West: US Clinical Trials Data Available In Booth ; Nutty Flavor & Healthy Boost of Omega-3 Make Hemp Seed an Ideal Ingredient; DSM's tensVida® Recognized for Innovative Development; Nutrition 21 Announces Addition of Innovative New Probiotic + Omega-3 Fish Oil Combination Product; Glanbia Nutritionals Offers More Than Ingredients for Nutritional Beverages; Whole Foods Market(R) Offers Natural Solutions to Help Build Up Body Defenses With Immune System Support; Doug Reyes Joins Embria as Regional Sales Manager; Michael F. Hines Joins Board of General Nutrition Centers, Inc.; Dr. Arnold Hirsch Celebrates 50th Anniversary with the American Chemical Society Gencor Announces Study Results Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men. Gencor Announces Study Results Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men. Gencor Announces Study Results Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men. Gencor Announces Study Results Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men. Gencor Announces Study Results Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men. Gencor Announces Study Results Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men. Gencor Announces Study Results Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men. Gencor Announces Study Results Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men. Gencor Announces Study Results Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men. Gencor Announces Study Results Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men. Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009 Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine. Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009 Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine. Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009 Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine. Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009 Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine. Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009 Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine. Sharp-GPC™ 45F by Enzymotec Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline. Sharp-GPC™ 45F by Enzymotec Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline. Sharp-GPC™ 45F by Enzymotec Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline. Sharp-GPC™ 45F by Enzymotec Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline. Sharp-GPC™ 45F by Enzymotec Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline. Sharp-GPC™ 45F by Enzymotec Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline. Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials. Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials. Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials. Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials. Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials. Taming Fear of the H1N1 Flu Vaccine Taming Fear of the H1N1 Flu Vaccine Natural Cold and Flu Remedies: Do They Help? Natural Cold and Flu Remedies: Do They Help? Exercise as Pain Therapy Exercise as Pain Therapy	QUEBEC CITY, Dec 08, 2005 /PRNewswire-FirstCall via COMTEX/ -- AEterna Zentaris Inc. (CA:AEZ)(AEZS) is pleased to announce that its subsidiary, Atrium Biotechnologies Inc. ("Atrium" TSX: ATB.sv), has acquired, effective today, Pittsburgh-based HVL Inc. ("Douglas") whose main brand is Douglas Laboratories. Douglas has been marketing health and nutritional products through healthcare practitioners for over 50 years and has current annual revenues of approximately $80 million. By acquiring Douglas, Atrium now positions itself as the leader in this sector throughout the United States. The transaction is immediately accretive to Atrium, enabling it to increase its adjusted earnings before interest, income taxes, depreciation and amortization (EBITDA) from approximately $31 million to about $48 million on a pro forma basis and therefore also increasing its earnings per share by more than 50%, before synergies. Following the transaction, Atrium's pro forma revenues will exceed $315 million. Under the agreement, Atrium will acquire Douglas for the total amount of $107 million ($US 92 million), which represents approximately 6.4 times the adjusted EBITDA generated by Douglas. Approximately $97 million will be paid in cash while the remainder, approximately $10 million, will be paid in Atrium subordinate voting shares issued to certain Douglas management shareholders at a price of $10.95 per share. The cash portion will come from Atrium's cash on hand and its newly re-negotiated credit facility that can be increased to $200 million, under certain conditions. "This significant acquisition represents Atrium's commitment to its aggressive corporate development strategy as well as immediately increases its EBITDA, net earnings and net earnings per share," stated Gilles Gagnon, President and Chief Executive Officer at AEterna Zentaris. Atrium Biotechnologies has issued a detailed press release on this transaction which is available on its Website at www.atrium-bio.com and also on SEDAR. About Atrium Atrium Biotechnologies Inc. is a leading developer, manufacturer and marketer of science-based products for the cosmetics, pharmaceutical, chemical and nutrition industries. Atrium focuses primarily on growing segments of the health and personal care markets which are benefiting from the trends towards healthy living and the ageing of the population. Atrium markets a broad portfolio of active ingredients, specialty chemicals and health and nutrition finished products through its highly specialized sales and marketing network in more than 35 countries, primarily in North America, Europe and Asia. Additional information about Atrium is available on its Web site at www.atrium-bio.com. About HVL / Douglas Founded in 1955, Douglas directly markets some 960 products to approximately 10,000 healthcare practitioners, such as physicians, chiropractors and osteopaths. The Company also sells supplements via distributors that work with health professionals. Douglas, which has approximately 250 employees, markets its products under various well-known brand names, including Douglas Laboratories, Advanced Medical Nutrition Incorporated (AMNI), Health Yourself and Intelligent Health. In addition to manufacturing and marketing its own exclusive brand name supplements, which make up the majority of its business, Douglas also designs and manufactures products for others in the industry. It has a 150,000 square-foot plant in Pittsburgh regrouping production facilities, warehouse facilities, laboratories and its head office. About AEterna Zentaris Inc. AEterna Zentaris Inc. is a growing global biopharmaceutical company engaged in the discovery, development and marketing of therapies for cancer and endocrine disorders. AEterna Zentaris also owns 48.5% of the equity of Atrium Biotechnologies Inc. (CA:ATBSV) and 64.9 % of its voting rights. Atrium is a developer, manufacturer and marketer of science-based products for the cosmetics, pharmaceutical, chemical and nutritional industries. News releases and additional information are available at www.aeternazentaris.com. Forward-Looking Statements This press release contains forward-looking statements made pursuant to the safe harbor provisions of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical studies, the ability of the Company to take advantage of business opportunities in the pharmaceutical industry, uncertainties related to the regulatory process and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. The Company does not undertake to update these forward-looking statements.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software